Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Otolaryngol Head Neck Surg. 2020 Apr;162(4):469-475. doi: 10.1177/0194599820904923. Epub 2020 Feb 18.
Identify risk factors and outcomes of recurrent well-differentiated thyroid cancer.
Retrospective case-control analysis.
Tertiary care academic center in Nashville, Tennessee.
This single-center analysis reviews 478 patients who underwent initial surgical management of well-differentiated thyroid carcinoma between 2002 and 2017. Patients were dichotomized with or without recurrent well-differentiated thyroid cancer. Demographic and clinicopathologic risk factors were carefully reviewed. Univariate, multiple regression, and survival analyses were used to evaluate predictors of recurrence.
Thirty-eight patients (7.9%) who received initial surgical intervention for well-differentiated thyroid carcinoma at our institution recurred, with an average time to recurrence of 24 months. Male sex, tumor size, multifocality, extrathyroidal extension, lymphovascular invasion, number of positive lymph nodes, and low lymph node yield were all significantly associated with locoregional recurrence ( < .05). Multiple regression analysis showed that extrathyroidal extension, number of positive lymph nodes, and low lymph node yield were independent factors predictive of posttreatment recurrence ( < .05). Metastatic lymph node ratio, the ratio of positive lymph nodes extracted to lymph node yield, of ≥0.3 is associated with increased risk of recurrence ( < .001) and decreased 5-year recurrence free survival ( < .001).
Extrathyroidal extension, number of positive lymph nodes, and low lymph node yield are independent clinicopathologic risk factors for postoperative recurrence of well-differentiated thyroid cancer. Metastatic lymph node ratio is uncommonly used but can be an important prognosticator of recurrence. Patients with metastatic lymph node ratio ≥0.3 should be counseled on their increased risk of recurrence and should undergo close surveillance following surgery.
确定复发性分化良好型甲状腺癌的危险因素和结局。
回顾性病例对照分析。
田纳西州纳什维尔的三级保健学术中心。
这项单中心分析回顾了 2002 年至 2017 年间在我院接受初始手术治疗分化良好型甲状腺癌的 478 例患者。患者分为有或无复发性分化良好型甲状腺癌。仔细审查了人口统计学和临床病理学危险因素。采用单变量、多元回归和生存分析来评估复发的预测因素。
在我们的机构中,有 38 名(7.9%)接受初始手术干预分化良好型甲状腺癌的患者复发,平均复发时间为 24 个月。男性、肿瘤大小、多灶性、甲状腺外侵犯、血管淋巴管侵犯、阳性淋巴结数量和低淋巴结产量均与局部区域复发显著相关(<0.05)。多元回归分析显示,甲状腺外侵犯、阳性淋巴结数量和低淋巴结产量是预测治疗后复发的独立因素(<0.05)。转移性淋巴结比率,即提取的阳性淋巴结与淋巴结产量的比值≥0.3,与复发风险增加(<0.001)和 5 年无复发生存率降低(<0.001)相关。
甲状腺外侵犯、阳性淋巴结数量和低淋巴结产量是分化良好型甲状腺癌术后复发的独立临床病理学危险因素。转移性淋巴结比率不常用,但可以作为复发的重要预后指标。转移性淋巴结比率≥0.3 的患者应告知其复发风险增加,并在手术后进行密切监测。